RAPPORT THERAPEUTICS INC (RAPP) Stock News

NASDAQ:RAPP - Nasdaq - US75383L1026 - Common Stock - Currency: USD

14.15 -0.21 (-1.46%)

After market: 13.87 -0.28 (-1.98%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

RAPP Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Benzinga - Mentions: ATAI KB SHG QS ...

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session

2 months ago - By: MarketBeat - Mentions: KYMR SNY VERA

Analysts Can't Get Enough of These Little-Known Biopharma Stocks

2 months ago - By: Benzinga - Mentions: TLPH FGEN MLTX TIL ...

12 Health Care Stocks Moving In Monday's After-Market Session

2 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates

2 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates

2 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference

2 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference

2 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics to Host 2025 Investor and Analyst Day

2 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics to Host 2025 Investor and Analyst Day

3 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business Update

3 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business Update

3 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics to Participate in Upcoming Investor Conferences

3 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics to Participate in Upcoming Investor Conferences

5 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting

5 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting

5 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

5 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

5 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development

5 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics to Participate in Upcoming Investor Conferences

5 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics to Participate in Upcoming Investor Conferences

7 months ago - By: Rapport Therapeutics, Inc.

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

7 months ago - By: Rapport Therapeutics, Inc.

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

7 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

7 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

8 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

8 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

9 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

9 months ago - By: Rapport Therapeutics, Inc.

Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting